Targets for SIRT1 mediated deacetylation include a broad range of transcription factors and co-activators governing many central metabolic pathways, and several different models of SIRT1 over-expression in transgenic mice were shown to prevent diabetes [110]. This evidence concerns the gene SIRT1 and diabetes mellitus.